ADARx Pharmaceuticals raised $446 million in a biotech IPO backed by AbbVie

ADARx Pharmaceuticals raised $446 million in a biotech IPO backed by AbbVie.

← Back to stories
National3 articles from 2 sources across the spectrum· Updated 3d ago

2 across the spectrum · tap a section to jump

Left

2 viewpoints
BloombergLean Left· 3d ago

Adarx Pharma Shares Climb 30% After $446.3 Million Upsized IPO

QuartzLean Left· 4d ago

ADARx Pharmaceuticals raised $446 million in a biotech IPO backed by AbbVie

BloombergLean Left· 4d ago

Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO

Center

0 viewpoints

No Center coverage yet.

A blind spot on this side of the story.

Right

0 viewpoints

No Right coverage yet.

A blind spot on this side of the story.

ADARx Pharmaceuticals raised $446 million in a biotech IPO backed by AbbVie | Slantwise